GNH USA

Europe — EMA

Meliglix 100 Mg (Sitagliptin Hydrochloride)

GNH USA supplies Meliglix 100 Mg (Sitagliptin Hydrochloride), a DPP‑4 inhibitor for type 2 diabetes mellitus. Request a quote for global supply.

Sitagliptin Hydrochloride

Request sourcing

1
Pack/s

What is Sitagliptin Hydrochloride?

Sitagliptin Hydrochloride, the active ingredient in Meliglix 100 Mg, is a dipeptidyl peptidase‑4 (DPP‑4) inhibitor presented as a 100 mg tablet for oral use. It is indicated for the management of type 2 diabetes mellitus in adult patients, helping to improve glycaemic control when used as part of a comprehensive diabetes treatment plan.

GNH USA supplies Meliglix 100 Mg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory conformity across markets and providing reliable logistics support for timely delivery.

What is Sitagliptin Hydrochloride used for?

Meliglix (sitagliptin) is used to improve glycaemic control in the type 2 diabetes therapeutic pathway. - Type 2 diabetes mellitus: lowers fasting and post‑prandial blood glucose levels. - Monotherapy in patients unsuitable for metformin: provides effective glucose reduction as a single oral agent. - Combination therapy with other antidiabetics: enhances overall glycaemic control when added to agents such as sulfonylureas or insulin.

What are the side effects of Sitagliptin Hydrochloride?

Sitagliptin is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nasopharyngitis: mild inflammation of the nasal passages and throat. - Headache: transient, mild to moderate intensity. - Upper respiratory tract infection: symptoms of cough, sore throat, or congestion. - Nausea: occasional mild gastrointestinal upset.

Serious or Rare Side Effects: - Pancreatitis: severe abdominal pain requiring immediate medical attention. - Severe allergic reactions: including Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic injury: elevated liver enzymes or jaundice. - Joint pain: unexplained arthralgia that may be persistent.

What precautions apply to Sitagliptin Hydrochloride?

When prescribing or dispensing Meliglix, consider the following safety measures. - Renal impairment: assess kidney function and adjust dose if necessary. - Hepatic impairment: monitor liver enzymes regularly. - History of pancreatitis: avoid use or discontinue promptly if symptoms recur. - Concomitant insulin or sulfonylureas: monitor for hypoglycaemia. - Pregnancy and lactation: safety not established; use only if benefits outweigh risks. - Store at ambient temperature: keep in the original container, protect from moisture and light.

What does Sitagliptin Hydrochloride interact with?

Sitagliptin may interact with other medicines; awareness of the interaction level is essential.

Major Interactions (Avoid): - Duplicate DPP‑4 inhibition: concurrent use with another DPP‑4 inhibitor can lead to excessive drug exposure. - Strong CYP3A4 inhibitors: may increase sitagliptin plasma levels, requiring caution.

Moderate Interactions (Monitor Closely): - Insulin or sulfonylureas: increased risk of hypoglycaemia, necessitating dose adjustments. - Diuretics causing dehydration: may affect renal clearance of sitagliptin. - Rifampin: may reduce sitagliptin effectiveness by inducing metabolism.

Frequently asked questions

What is Meliglix 100 Mg used for?+
Meliglix 100 Mg contains sitagliptin hydrochloride, a DPP‑4 inhibitor indicated for the treatment of type 2 diabetes mellitus in adults. It is used to improve glycaemic control when combined with diet, exercise, and other antidiabetic therapies as prescribed by a healthcare professional.
How does sitagliptin hydrochloride work?+
Sitagliptin hydrochloride blocks the enzyme dipeptidyl peptidase‑4, which normally breaks down the incretin hormones GLP‑1 and GIP. By preserving these hormones, the drug enhances glucose‑dependent insulin secretion and reduces glucagon release, leading to lower blood glucose levels.
What is the usual dose of Meliglix 100 Mg?+
The prescribed dose of Meliglix 100 Mg is determined by the treating physician based on individual patient factors such as renal function, glycaemic targets, and concomitant medications. Patients should follow the dosing instructions provided by their healthcare provider.
Is Meliglix safe during pregnancy or breastfeeding?+
Safety of sitagliptin during pregnancy or lactation has not been fully established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by the prescribing clinician.
How do I order Meliglix 100 Mg from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.
How does Meliglix compare with other antidiabetic drugs?+
Meliglix (sitagliptin) belongs to the DPP‑4 inhibitor class, which differs from sulfonylureas, metformin, or insulin. DPP‑4 inhibitors provide glucose‑dependent insulin release with a low risk of hypoglycaemia and are often used when metformin alone is insufficient or contraindicated.
What are the storage requirements for Meliglix 100 Mg?+
Meliglix 100 Mg tablets should be stored at ambient temperature, below 25 °C, in the original blister pack or container. Protect them from excess moisture, heat, and direct sunlight to maintain product stability.
How is Meliglix 100 Mg administered?+
Meliglix 100 Mg is taken orally, usually once daily, with or without food, as directed by the prescribing physician. The tablet should be swallowed whole with water and not chewed or crushed.
What are the most serious risks associated with Meliglix?+
Serious risks include pancreatitis, severe allergic reactions such as Stevens‑Johnson syndrome, and rare cases of hepatic injury. Patients should seek immediate medical attention if they experience persistent abdominal pain, rash, or signs of liver dysfunction.
Who should not use Meliglix 100 Mg?+
Meliglix should be avoided in patients with a known hypersensitivity to sitagliptin or any component of the formulation, and in those with a history of pancreatitis. Caution is also advised for individuals with severe renal impairment unless dose adjustments are made.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Sitagliptin Hydrochloride
Route
Oral Use
Manufacturer
Pharmazac Sa
Origin
EU

Related products

Disit

Disit

Sitagliptin Hydrochloride

Laboratorios Alter, S.A.
EU
Jazeta

Jazeta

Sitagliptin Hydrochloride

Zentiva, K.S.
EU
Jazeta

Jazeta

Sitagliptin Hydrochloride

Zentiva, K.S.
EU
Jazeta

Jazeta

Sitagliptin Hydrochloride

Zentiva, K.S.
EU